Skip to content


19 December 2022

Fewer long-term investments were made in the companies behind the nuclear weapons industry, according to the Don’t Bank on the Bomb report, published today by PAX and ICAN. The report found a $45.9 billion drop in long-term investments in 2022, including loans and underwriting.

Analysis suggests that the long-term trend “could signal that a growing number of long-term investors do not see nuclear weapon production as a sustainable growth market and regard the companies involved as an avoidable risk. It also reflects the changes in the legal context: Increasingly, mandatory due diligence legislation in Europe, and the anticipation of such laws, is raising questions around investments in arms producers.”

 Key findings include:
$747 billion invested in 24 nuclear weapon producing companies.
$746,677 million was made available to the nuclear weapons producing companies between January 2020 and July 2022, a $61.5 billion increase from the previous year. The increase can be attributed to an increase in shareholding in 2022 compared to 2021. Bondholding values dropped by $1 billion. Loans and underwriting also decreased with $31.2 billion and $14.7 billion respectively.
306 financial institutions invest
306 institutions have financing or investment relationships with the 24 nuclear weapon producing companies.
Northrop Grumman is biggest single nuclear weapons profiteer
Northrop Grumman is the biggest single nuclear weapons profiteer, with at least $24.3 billion in contracts, not including consortium and joint venture revenues. Aerojet Rocketdyne, BAE Systems, Boeing, Lockheed Martin and Raytheon Technologies also hold multi-billion-dollar contracts for nuclear weapon production and/or stockpiling.